Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2026)
Anavex Life Sciences (AVXL) posted Total Non-Current Liabilities of $6.25 million for fiscal Q2 2026 (quarter ended Mar 31, 2026), up 12.4% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Total Non-Current Liabilities came in at $8.14 million, down 43.7% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Total Non-Current Liabilities was $14.46 million in FY2024 (+24.5%), $11.62 million in FY2023 (+18.9%), $9.77 million in FY2022 (-5.7%) and $10.36 million in FY2021 (+41.8%).
- Quarterly Total Non-Current Liabilities has run from a low of $5.57 million in fiscal Q1 2026 to a high of $14.46 million in fiscal Q4 2024 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.25 Mn |
| Dec 31, 2025 | 5.57 Mn |
| Sep 30, 2025 | 8.14 Mn |
| Sep 30, 2024 | 14.46 Mn |
| Sep 30, 2023 | 11.62 Mn |
| Sep 30, 2022 | 9.77 Mn |
| Sep 30, 2021 | 10.36 Mn |
| Sep 30, 2020 | 7.31 Mn |
| Jun 30, 2014 | 1.91 Mn |
| Mar 31, 2014 | 1.88 Mn |
| Dec 31, 2013 | 1.82 Mn |
| Sep 30, 2013 | 1.95 Mn |
| Sep 30, 2012 | 2.89 Mn |
API Access
Anavex Life Sciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();